Research Library
FOUNDATIONAL

ACTH 1-39

Also known as: Adrenocorticotropic hormone, Corticotropin, ACTH 1-39

Endocrine SignalingReceptor Pharmacology
Classification39-amino-acid melanocortin peptide (full-length ACTH).
Catalog / SKUACTH 1-39 · MX-ACTH139-005 · 5 mg
TargetsMelanocortin receptors (esp. MC2R); HPA axis

Molecular Overview

ACTH 1-39 is full-length adrenocorticotropic hormone, a foundational component of the hypothalamic-pituitary-adrenal (HPA) axis acting via melanocortin receptors.

Mechanistic Background

ACTH activates melanocortin receptors (notably MC2R) to regulate adrenal steroidogenesis, extensively described in endocrinology.

What Researchers Study

Research spans melanocortin-receptor biology and HPA-axis regulation.

Evidence Landscape

Current evidence level: FOUNDATIONAL. Preclinical evidence does not equate to demonstrated human efficacy.

Research Limitations

Educational reference only; not a treatment recommendation.

Research Use Only

Molecularix Biolabs provides research materials for legitimate laboratory research. Information in this Research Library is provided for educational and scientific reference purposes and is not medical advice, treatment guidance, or a recommendation for human or veterinary use.